Supplier
Alvarado Hospital, LLC
Alvarado Hospital, LLC was paid $11.46M by Medicaid between Jan 2018 and Dec 2023, across 158 billing codes. Its largest line is 99499, — 16% of everything it billed.
33Billing provider infoALVARADO HOSPITAL, LLC
SAN DIEGO, CA 92120
SAN DIEGO, CA 92120
33aNPI1265468946assigned 06/24/2006
33bProvider typePharmacy
28Total paid$11.46M
24GClaims387,833
24DCodes billed158
24AFirst – last monthJan 2018 – Dec 2023
Compared with peers
Next to other Pharmacy providers in California
Rank by total paid#4 of 179
Median peer was paid$2K
This provider vs. median6,501×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 51,271 | $2.02M | |
| 2019 | 44,035 | $1.76M | |
| 2020 | 51,915 | $1.35M | |
| 2021 | 71,720 | $1.93M | |
| 2022 | 92,832 | $2.37M | |
| 2023 | 76,060 | $2.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99499 | 16% | 11,014 | 8,472 | $1.81M | |
| 0450 | Emergency room services | 13% | 23,325 | 20,935 | $1.47M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.0% | 16,095 | 14,539 | $916K |
| 0121 | 5.3% | 348 | 308 | $613K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.9% | 9,173 | 8,547 | $556K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.0% | 1,590 | 1,525 | $341K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 2.9% | 5,394 | 4,798 | $336K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 3,113 | 3,005 | $308K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.4% | 11,969 | 10,773 | $272K |
| Z7502 | 2.0% | 5,988 | 5,878 | $224K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.8% | 2,381 | 2,265 | $211K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.7% | 8,541 | 7,463 | $199K |
146 more codes
| 80053 | Comprehensive metabolic panel | 1.7% | 20,849 | $189K |
| 99284 | Emergency room visit (serious) | 1.6% | 2,917 | $185K |
| 0300 | 1.6% | 361 | $185K | |
| 0250 | 1.6% | 6,228 | $181K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 26,404 | $165K |
| 99199 | Unlisted special service, procedure or report | 1.4% | 3,173 | $158K |
| 0730 | 1.4% | 192 | $157K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 5,763 | $152K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 1,908 | $129K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 4,323 | $129K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 6,887 | $122K |
| 0270 | <1% | 6,171 | $113K | |
| 0301 | <1% | 182 | $113K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,928 | $112K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 5,452 | $102K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,452 | $94K |
| 71045 | Radiologic examination, chest; single view | <1% | 9,182 | $93K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 927 | $93K |
| J3490 | Unclassified drugs | <1% | 41,232 | $91K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,223 | $89K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,240 | $87K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,407 | $78K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 443 | $71K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,843 | $64K |
| 84484 | <1% | 7,904 | $61K | |
| 83690 | <1% | 8,696 | $52K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,016 | $51K |
| 0636 | <1% | 57 | $47K | |
| 83880 | <1% | 2,393 | $47K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,001 | $41K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 597 | $38K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,011 | $37K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,597 | $35K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,785 | $34K |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 767 | $34K |
| 90715 | <1% | 825 | $33K | |
| 0762 | <1% | 34 | $30K | |
| 81025 | <1% | 6,075 | $30K | |
| 93970 | <1% | 130 | $26K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,440 | $26K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,637 | $25K |
| 0305 | <1% | 182 | $25K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,115 | $23K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,268 | $21K |
| 73630 | <1% | 885 | $20K | |
| 81001 | <1% | 7,109 | $20K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 907 | $19K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 910 | $18K |
| 0306 | <1% | 117 | $18K | |
| 73562 | <1% | 894 | $18K | |
| 87040 | <1% | 2,280 | $17K | |
| 0258 | <1% | 300 | $15K | |
| 0324 | <1% | 151 | $14K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,976 | $14K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,001 | $14K |
| Z7610 | <1% | 1,208 | $14K | |
| 73610 | <1% | 577 | $13K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 240 | $13K |
| 81003 | <1% | 6,573 | $13K | |
| 73130 | <1% | 537 | $13K | |
| 83605 | <1% | 1,604 | $12K | |
| 87186 | <1% | 1,752 | $12K | |
| 73030 | <1% | 477 | $12K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 89 | $12K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 63 | $11K |
| 0460 | <1% | 79 | $11K | |
| 82962 | <1% | 5,219 | $9K | |
| 87070 | <1% | 1,137 | $9K | |
| 76830 | Ultrasound, transvaginal | <1% | 144 | $9K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 427 | $9K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 950 | $9K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 477 | $8K |
| 72100 | <1% | 304 | $8K | |
| 97139 | <1% | 59 | $8K | |
| 99152 | <1% | 130 | $7K | |
| 99406 | <1% | 564 | $6K | |
| 85730 | <1% | 1,319 | $6K | |
| 85610 | <1% | 1,973 | $6K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,450 | $6K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,094 | $6K |
| 0272 | <1% | 321 | $6K | |
| 87077 | <1% | 1,238 | $6K | |
| 84702 | <1% | 633 | $5K | |
| 85379 | <1% | 586 | $5K | |
| 93971 | <1% | 52 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 482 | $4K |
| 83735 | <1% | 1,346 | $4K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 727 | $4K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 827 | $4K |
| J1815 | Injection, insulin, per 5 units | <1% | 647 | $4K |
| 70486 | <1% | 27 | $3K | |
| 97161 | <1% | 74 | $3K | |
| 94060 | <1% | 87 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,816 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 262 | $3K |
| 82550 | <1% | 454 | $2K | |
| 73502 | <1% | 108 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 875 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 459 | $2K |
| 0307 | <1% | 74 | $2K | |
| 0360 | <1% | 13 | $2K | |
| G0378 | Hospital observation service, per hour | <1% | 32 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 33 | $2K |
| 97750 | <1% | 54 | $2K | |
| 94729 | <1% | 43 | $2K | |
| 0710 | <1% | 18 | $2K | |
| 85027 | <1% | 346 | $2K | |
| 99153 | Mod sedat endo service >5yrs | <1% | 96 | $2K |
| 87420 | <1% | 226 | $1K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $1K |
| 94727 | <1% | 42 | $1K | |
| 84703 | <1% | 243 | $1K | |
| 96376 | <1% | 252 | $996.62 | |
| 86140 | <1% | 210 | $960.37 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 170 | $952.79 |
| 73110 | <1% | 39 | $937.93 | |
| J2704 | Injection, propofol, 10 mg | <1% | 29 | $923.16 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 96 | $894.90 |
| 86901 | <1% | 294 | $790.84 | |
| 85007 | <1% | 292 | $766.23 | |
| 86900 | <1% | 295 | $743.00 | |
| 10060 | <1% | 13 | $592.92 | |
| 81002 | <1% | 251 | $513.15 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 207 | $475.47 |
| 76999 | <1% | 13 | $454.17 | |
| 80061 | Lipid panel | <1% | 264 | $418.48 |
| 86850 | <1% | 93 | $387.12 | |
| 71010 | <1% | 23 | $342.47 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 63 | $330.41 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 39 | $301.59 |
| 84145 | <1% | 30 | $291.40 | |
| 73080 | <1% | 12 | $270.46 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 164 | $245.48 |
| 87081 | <1% | 37 | $211.07 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 25 | $167.73 |
| 87210 | <1% | 39 | $157.50 | |
| 85651 | <1% | 80 | $148.77 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 31 | $138.14 |
| 82553 | <1% | 13 | $125.70 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 15 | $123.14 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 36 | $121.54 |
| 0271 | <1% | 160 | $111.13 | |
| 84100 | <1% | 71 | $44.72 | |
| 87205 | <1% | 12 | $18.58 | |
| A4615 | Cannula, nasal | <1% | 34 | $15.46 |
| A9270 | Non-covered item or service | <1% | 53 | $11.41 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOAN, CHRISTOPHER (CHIEF COMPLIANCE COUNSEL)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.